Abstract
We prospectively investigated the short-term effects of intravenous methyl-prednisolone (IVMP) on cerebral volume in patients suffering a multiple sclerosis (MS) relapse. Ten patients underwent MRI brain studies immediately before and after IVMP treatment, and 4 and 8 weeks later. Whole brain volumes decreased significantly over the 8-week period. The greatest change occurred during IVMP administration. This has implications for MS treatment trials using cerebral atrophy as an endpoint.
Original language | English |
---|---|
Pages (from-to) | 636-638 |
Number of pages | 3 |
Journal | Journal of Clinical Neuroscience |
Volume | 13 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Jul 2006 |
Externally published | Yes |
Keywords
- Cerebral atrophy
- Cerebral volume
- Methylprednisolone
- Multiple sclerosis